Docetaxel, cisplatin and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216)

BACKGROUND: In an effort to optimize non-operative therapy in patients with locoregionally advanced head and neck squamous cell cancer, the Southwest Oncology Group conducted a phase II trial combining three-drug taxane-containing induction chemotherapy with accelerated fractionation/concomitant boo...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Adelstein, David J., Moon, James, Hanna, Ehab, Giri, P.G. Shankar, Mills, Glenn M., Wolf, Gregory T., Urba, Susan G.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2010
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2967367/
https://ncbi.nlm.nih.gov/pubmed/19557750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hed.21179
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg